Variation in incidence and fatality of melanoma by season of diagnosis in New South Wales, Australia

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 3, 2006, Pages 524-528

  Boniol, Mathieu ^a,b   Armstrong, Bruce K ^c   Doré, Jean François ^a  

^a INSERM   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CORRELATION ANALYSIS; EARLY DIAGNOSIS; FATALITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SEASONAL VARIATION; SUMMER; SUN EXPOSURE; SURVIVAL RATE; WINTER;

ADULT; AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; NEW SOUTH WALES; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEASONS; SEX DISTRIBUTION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; ULTRAVIOLET RAYS;

EID: 33645512775     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0684     Document Type: Article

References (18)

1. Boniol M, de Vries E, Coebergh JW, Dore JF. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the EUROCARE group of registries. Eur J Cancer 2005;41:126-32.
2. Akslen LA, Hartveit F. Cutaneous melanoma-season and invasion? A preliminary report. Acta Derm Venereol 1988;68:390-4.
3. Braun MM, Tucker MA, Devesa SS, Hoover RN. Seasonal variation in frequency of diagnosis of cutaneous malignant melanoma. Melanoma Res 1994;4:235-41.
4. Nam JM. Interval estimation and significance testing for cyclic trends in seasonality studies. Biometrics 1995;51:1411-7.
5. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-220.
6. Aitken JF, Janda M, Lowe JB, et al. Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Cancer Causes Control 2004;15:453-63.
7. Janda M, Youl PH, Lowe JB, Elwood M, Ring IT, Aitken JF. Attitudes and intentions in relation to skin checks for early signs of skin cancer. Prev Med 2004;39:11-8.
8. Schwartz SM, Armstrong BK, Weiss NS. Seasonal variation in the incidence of cutaneous malignant melanoma: an analysis by body site and histologic type. Am J Epidemiol 1987;126:104-11.
9. Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ko S, Pipitone MA, Abdel-Malek ZA. Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round? Pigment Cell Res 2003;16:434-47.
10. Armstrong BK, Heenan PJ, Caruso V, Glancy RJ, Holman CD. Seasonal variation in the junctional component of pigmented naevi. Int J Cancer 1984;34:441-2.
11. Fleming MG, Swan LS, Heenan PJ. Seasonal variation in the proliferation fraction of Australian common nevi. Am J Dermatopathol 1991;13:463-6.
12. Berwick M, Armstrong BK, Ben Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:195-9.
13. Robsahm TE, Tretli S, Dahlback A, Moan J. Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway). Cancer Causes Control 2004;15:149-58.
14. Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 2005;97:161-3.
15. Giovannucci E. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control 2005;16:83-95.
16. Beer TM, Eilers KM, Garzotto M, Egorin MJ, Lowe BA, Henner WD. Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer. J Clin Oncol 2003;21:123-8.
17. Liu G, Wilding G, Staab MJ, et al. Phase II study of 1α- hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer. Clin Cancer Res 2003;9:4077-83.
18. Hussein MR, Haemel AK, Sudilovsky O, Wood GS. Genomic instability in radial growth phase melanoma cell lines after ultraviolet irradiation. J Clin Pathol 2005;58:389-96.